Alkermes Announces Settlement With Teva Related to VIVITROL Patent Litigation
Portfolio Pulse from Benzinga Newsdesk
Alkermes has announced a settlement with Teva Pharmaceuticals in relation to patent litigation over VIVITROL. The details of the settlement have not been disclosed.
August 30, 2023 | 11:25 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alkermes has settled a patent litigation with Teva Pharmaceuticals. This could potentially reduce legal costs and uncertainty for the company.
The settlement of the patent litigation could potentially reduce legal costs for Alkermes, as well as remove a source of uncertainty. This could have a positive impact on the company's stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100